Andreas Crameri

Maxygen (United States)

Papers

1

Total Citations

127

H-Index

1

About

Andreas Crameri is a pioneering molecular biologist whose work has fundamentally advanced the field of directed evolution and protein engineering. His research focuses on the development of innovative methods for creating novel enzymes and therapeutic proteins with enhanced or entirely new functions. Crameri’s most significant contribution is his seminal work on DNA family shuffling, a powerful technique that accelerates the evolution of proteins by recombining sequences from related genes. His landmark 1999 paper, "Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling," which has garnered over 127 citations, demonstrated the method's efficacy by engineering a thymidine kinase variant with dramatically improved activity for phosphorylating the prodrug AZT—a key step in antiviral therapy. This breakthrough not only provided a critical tool for drug development but also established a foundational strategy for creating custom biocatalysts and therapeutic antibodies. Crameri’s work has had a lasting impact on synthetic biology and biotechnology, inspiring countless researchers to harness the power of evolutionary design for solving complex biological challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
127
Total Citations
127
Avg Citations/Paper
🏆 Most Cited Paper
Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling
127 citations · 1999
📈 Most Prolific Year: 1999 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Maxygen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago